Back to search

Article

Fluralaner 5.46% (W/W) Flavored Chewable Tablet (Bravecto® 1-Month) Is Effective for Treatment of Canine Generalized Demodicosis

2021-10-05

Abstract excerpt

<h4>Background: </h4> Orally administered fluralaner (13.64% w/w) is effective for treating canine generalized demodicosis. A study was initiated to assess the efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation for monthly administration in the treatment of this disease. <h4>Methods: </h4>: Client-owned dogs diagnosed with generalized demodicosis were acclimatized to laboratory conditions and ran...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9123e833-4984-552d-9524-1416b3faa364
DOI
10.21203/rs.3.rs-948420/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fluralaner 5.46% (W/W) Flavored Chewable Tablet (Bravecto® 1-Month) Is Effective for Treatment of Canine Generalized DemodicosisDOI 10.21203/rs.3.rs-948420/v1
A European Field Assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosisSemantic proximity
Safety of Simparica Trio® (sarolaner, pyrantel, moxidectin) in heartworm-infected dogsSemantic proximity
Insecticidal efficacy of fluralaner (Bravecto®) against Triatoma brasiliensis, a major vector of Trypanosoma cruzi in BrazilSemantic proximity
Epidemiology and preclinical management of dog bites among humans in Wakiso and Kampala districts, Uganda: Implications for prevention of dog bites and rabiesSemantic proximity
Impact of lokivetmab for Canine Atopic Dermatitis on Owner and Canine Health-Related Quality of Life and Owner Treatment SatisfactionSemantic proximity
Brown dog tick, Rhipicephalus sanguineus sensu lato, infestation of susceptible dog hosts is reduced by slow release of semiochemicals from a less susceptible host.Semantic proximity
ABCB1-1 Delta (MDR1-1 Delta) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis.Semantic proximity
The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.Semantic proximity
Evaluation of the safety of spinosad and milbemycin 5-oxime orally administered to Collies with the MDR1 gene mutation.Semantic proximity
Clearance of plasma ivermectin with single pass lipid dialysis in 2 dogs.Semantic proximity
Acceptance of Oclacitinib Maleate (Apoquel®) Chewable Tablets In Client-Owned Dogs With Allergic And Atopic Dermatitis.Semantic proximity
Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation.Semantic proximity
Select a neighboring publication to make it the new centre.